Literature DB >> 31726187

Granulysin: The attractive side of a natural born killer.

E Sparrow1, M D Bodman-Smith2.   

Abstract

First discovered in the 1980's, granulysin has until recently been thought of solely as an effector molecule present within cytotoxic immune cell populations, and involved in the direct killing of pathogens and infected or transformed eukaryotic cells. However, recent research has suggested an additional role of granulysin, in particular the 15 kDa isoform. While 9 kDa granulysin is broadly cytotoxic and capable of the direct killing of bacteria and other pathogens, the 15 kDa isoform of this molecule has been shown to function as an immune 'alarmin', causing the maturation and migration of antigen-presenting cells and other cells of the immune system. This dual function of granulysin indirectly increases the immune response to an infection or tumour, and therefore escalates its importance in the immune system. Here we review the different roles of granulysin, both as a cytotoxic molecule, and as a modulator of the immune system, and discuss the impact this molecule may have on the response to tumour and infection.
Copyright © 2019 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chemotaxis; Cytotoxicity; Granulysin

Year:  2019        PMID: 31726187     DOI: 10.1016/j.imlet.2019.11.005

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  15 in total

1.  Identification of an immune gene-associated prognostic signature in patients with bladder cancer.

Authors:  Zhiqiang Wang; Liping Zhu; Li Li; Justin Stebbing; Zibing Wang; Ling Peng
Journal:  Cancer Gene Ther       Date:  2022-02-15       Impact factor: 5.987

2.  Preclinical Studies of Granulysin-Based Anti-MUC1-Tn Immunotoxins as a New Antitumoral Treatment.

Authors:  Patricia Guerrero-Ochoa; Raquel Ibáñez-Pérez; Germán Berbegal-Pinilla; Diederich Aguilar; Isabel Marzo; Francisco Corzana; Martha Minjárez-Sáenz; Javier Macías-León; Blanca Conde; Javier Raso; Ramón Hurtado-Guerrero; Alberto Anel
Journal:  Biomedicines       Date:  2022-05-24

3.  Bacillus Calmette-Guerin (BCG) induces superior anti-tumour responses by Vδ2+ T cells compared with the aminobisphosphonate drug zoledronic acid.

Authors:  J Fenn; L A Ridgley; A White; C Sarfas; M Dennis; A Dalgleish; R Reljic; S Sharpe; M Bodman-Smith
Journal:  Clin Exp Immunol       Date:  2022-06-23       Impact factor: 5.732

Review 4.  Translating Unconventional T Cells and Their Roles in Leukemia Antitumor Immunity.

Authors:  Nilberto Dias de Araújo; Fábio Magalhães Gama; Mateus de Souza Barros; Thaís Lohana Pereira Ribeiro; Fabíola Silva Alves; Lilyane Amorim Xabregas; Andréa Monteiro Tarragô; Adriana Malheiro; Allyson Guimarães Costa
Journal:  J Immunol Res       Date:  2021-01-07       Impact factor: 4.818

Review 5.  How to Train Your Dragon: Harnessing Gamma Delta T Cells Antiviral Functions and Trained Immunity in a Pandemic Era.

Authors:  Jonathan Caron; Laura Alice Ridgley; Mark Bodman-Smith
Journal:  Front Immunol       Date:  2021-03-29       Impact factor: 7.561

6.  Case Report: Single-Cell Transcriptomic Analysis of an Anaplastic Oligodendroglioma Post Immunotherapy.

Authors:  Guangyang Yu; Madison K Butler; Abdalla Abdelmaksoud; Ying Pang; Yu-Ting Su; Zachary Rae; Kimia Dadkhah; Michael C Kelly; Young K Song; Jun S Wei; Masaki Terabe; Ramya Atony; Kelly Mentges; Brett J Theeler; Marta Penas-Prado; John Butman; Kevin Camphausen; Kareem A Zaghloul; Edjah Nduom; Martha Quezado; Kenneth Aldape; Terri S Armstrong; Mark R Gilbert; James L Gulley; Javed Khan; Jing Wu
Journal:  Front Oncol       Date:  2021-01-14       Impact factor: 6.244

7.  A Missense Variant in Granulysin is Associated with the Efficacy of Pegylated-Interferon-Alpha Therapy in Chinese Patients with HBeAg-Positive Chronic Hepatitis B.

Authors:  Jing Li; Haitao Chen; Jiaxuan Chen; Bin Zhou; Jinlin Hou; De-Ke Jiang
Journal:  Pharmgenomics Pers Med       Date:  2021-11-23

Review 8.  The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies.

Authors:  Tobias Bald; Matthew F Krummel; Mark J Smyth; Kevin C Barry
Journal:  Nat Immunol       Date:  2020-07-20       Impact factor: 25.606

9.  Stratification of COVID-19 patients based on quantitative immune-related gene expression in whole blood.

Authors:  Josefine Persson; Björn Andersson; Suzanne van Veen; Mariëlle C Haks; Ogonna Obudulu; Sara Torkzadeh; Tom H M Ottenhoff; Nelly Kanberg; Magnus Gisslén; Lars-Magnus Andersson; Ali M Harandi
Journal:  Mol Immunol       Date:  2022-03-04       Impact factor: 4.407

10.  Distinct populations of antigen-specific tissue-resident CD8+ T cells in human cervix mucosa.

Authors:  Tao Peng; Khamsone Phasouk; Emily Bossard; Alexis Klock; Lei Jin; Kerry J Laing; Christine Johnston; Noel A Williams; Julie L Czartoski; Dana Varon; Annalyssa N Long; Jason H Bielas; Thomas M Snyder; Harlan Robins; David M Koelle; M Juliana McElrath; Anna Wald; Lawrence Corey; Jia Zhu
Journal:  JCI Insight       Date:  2021-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.